DE LA TORRE, A. Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates. Canadian Hematology Today, Toronto, Canada, v. 2, n. 2, p. 16–19, 2023. DOI: 10.58931/cht.2023.2233. Disponível em: https://canadianhematologytoday.com/article/view/2-2-de_la_Torre. Acesso em: 18 oct. 2024.